BioXcel Therapeutics
$0.00 (0.00%) Today
-$0.54 (-4.72%) As of 10:43 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.
About BTAI
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
CEO
Vimal D. Mehta
Employees
89
Headquarters
New Haven, Connecticut
Founded
2017
BTAI Key Statistics
Market cap
320.43M
Price-Earnings ratio
—
Dividend yield
—
Average volume
611.00K
High today
$11.83
Low today
$11.28
Open price
$11.41
Volume
443.99K
52 Week high
$39.00
52 Week low
$9.08
Analyst ratings
89%
of 9 ratings
Buy
88.9%
Hold
0%
Sell
11.1%
BTAI Earnings
-$1.15
-$0.77
-$0.38
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market